The list of AEFI for Covishield include injection site tenderness, injection site pain, headache fatigue, myalgia, malaise, pyrexia, chills and arthralgia nausea
"Covishield and Covaxin, the two COVID-19 vaccines which have received Emergency Use Authorisation (EAU) have been tested on thousands of people and side-effects are negligible"
New Delhi: The much-anticipated inoculation programme against Covid-19 in the country is expected to begin by January 12, said government sources. “In all likelihood, the Covid immunisation drive is expected to start early next week. Considering the preparations, the roll-out programme may start on January 11 or latest by January 12,” a senior government official […]
"SII has applied for emergency use authorisation to DCGI. The application will be reviewed by the expert committee and after that final call will be taken," a senior government official confirmed ANI.